09/10/2024
5:30 PM | Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13D/A | |
09/05/2024
5:37 PM | Soleno Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13G | |
08/30/2024
5:33 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
5:34 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
5:35 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
5:36 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
6:36 PM | Soleno Therapeutics (Issuer)
Vivo Opportunity Fund Holdings, L.P. (Reporting)
Vivo Opportunity, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/23/2024
6:14 PM | Soleno Therapeutics (Issuer)
Urbanski Raymond W. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/23/2024
6:16 PM | Soleno Therapeutics (Issuer)
Urbanski Raymond W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
5:16 PM | Bir Dawn Carter (Reporting)
Soleno Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/16/2024
5:18 PM | Bir Dawn Carter (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
5:55 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
5:56 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
5:56 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
5:57 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
4:18 PM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
3:54 PM | Soleno Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/07/2024
3:00 PM | Soleno Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/19/2024
4:02 PM | Soleno Therapeutics (Filer)
| Form 424B5 | |
07/19/2024
4:04 PM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2024
8:00 AM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
8:01 AM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2024
8:01 AM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
8:02 AM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
8:02 AM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
8:03 AM | Huang Michael F. (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
8:04 AM | Manning Meredith (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
4:56 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
4:58 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
4:58 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
5:00 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
4:13 PM | Melincoff Gwen A (Reporting)
Soleno Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2024
3:17 PM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2024
7:49 PM | MARIO ERNEST (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
7:50 PM | Pauls Matthew (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
7:51 PM | Sinclair Andrew (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
7:52 PM | Soleno Therapeutics (Issuer)
Volck Birgitte (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
7:46 PM | Harris William G (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
3:29 PM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2024
6:11 PM | MARIO ERNEST (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
4:28 PM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Why You Should NOT Trade This Market (Ad) You'll be interested in our 5-Day Options Trading Challenge, starting September 23.
So, what makes this different from every other options research you may have seen?
Well, for starters... most of them want you to first BUY their service... which is usually thousands of dollars... Just click here to get the full details on the 5-Day Options Trading Challenge, before this offer go |
05/01/2024
12:07 PM | Soleno Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13D/A | |
05/01/2024
12:10 PM | Soleno Therapeutics (Issuer)
Vivo Opportunity Fund Holdings, L.P. (Reporting)
Vivo Opportunity, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
4:53 PM | Huang Michael F. (Reporting)
Soleno Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/30/2024
4:54 PM | Manning Meredith (Reporting)
Soleno Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/22/2024
4:06 PM | Soleno Therapeutics (Filer)
| Form ARS | |
04/22/2024
3:31 PM | Soleno Therapeutics (Filer)
| Form DEF 14A | |
04/22/2024
3:15 PM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/03/2024
8:36 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
8:37 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
8:39 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
8:40 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
5:06 AM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
4:35 PM | JANUS HENDERSON GROUP PLC (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13G/A | |
02/07/2024
7:01 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13G/A | |
01/30/2024
3:57 PM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2024
4:42 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
4:44 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
4:47 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
3:31 PM | MARIO ERNEST (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
4:34 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
4:35 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
4:36 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
4:37 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
3:16 PM | Soleno Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/15/2023
5:00 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
6:57 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/14/2023
4:09 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023
8:32 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
8:32 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
8:34 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
8:34 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
3:46 PM | Soleno Therapeutics (Subject)
Yen Kristen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023
3:53 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023
5:17 PM | Soleno Therapeutics (Subject)
Yen Kristen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2023
6:05 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2023
6:21 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/04/2023
7:41 PM | MARIO ERNEST (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
7:02 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
7:03 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
7:04 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
7:06 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
8:50 PM | Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
8:51 PM | Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
8:52 PM | Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
8:52 PM | Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
11:15 PM | Soleno Therapeutics (Filer)
| Form EFFECT | |
10/23/2023
3:20 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13D/A | |
10/20/2023
3:32 PM | Soleno Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/16/2023
3:30 PM | Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13D/A | |
10/12/2023
3:30 PM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13G | |
Who are Nvidia’s New Silent Partners? (Ad) Nvidia recently became just the third $2 trillion company.
But Nvidia can’t do everything by itself. I call these Nvidia’s “Silent Partners.” |
10/12/2023
3:05 PM | COMMODORE CAPITAL LP (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13G | |
10/11/2023
3:30 PM | Soleno Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13D/A | |
10/10/2023
3:30 PM | Fairmount Funds Management LLC (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13G | |
10/06/2023
10:45 AM | JANUS HENDERSON GROUP PLC (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13G | |
10/05/2023
4:09 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Soleno Therapeutics (Subject)
| Form SC 13G | |
10/04/2023
3:30 PM | Soleno Therapeutics (Issuer)
Vivo Opportunity Fund Holdings, L.P. (Reporting)
Vivo Opportunity, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2023
9:36 AM | Soleno Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
10/02/2023
6:54 PM | Abingworth Bioventures VII LP (Reporting)
Abingworth LLP (Reporting)
Carlyle Genesis UK LLC (Reporting)
Carlyle Group Inc. (Reporting)
Carlyle Group Inc. (Reporting)
Carlyle Holdings I GP Inc. (Reporting)
Carlyle Holdings I GP Sub L.L.C. (Reporting)
Carlyle Holdings I L.P. (Reporting)
Carlyle Investment Management LLC (Reporting)
CG Subsidiary Holdings L.L.C. (Reporting)
Soleno Therapeutics (Issuer)
TC Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/29/2023
3:51 PM | Soleno Therapeutics (Filer)
| Form 424B5 | |
